Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 331
Selected: 0
NCT IDTitle
NCT06915168CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
NCT04703920Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer
NCT00141713The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease
NCT02400190The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NCT06866262Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
NCT00581256A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer
NCT00156286Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC
NCT04497038Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
NCT04925089Localized Leiomyosarcoma Biomarker Protocol
NCT00645359Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma
NCT01790568Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant
NCT01639417Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients
NCT04431635Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma
NCT04396808Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
NCT01975597Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
NCT00134355Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer
NCT02677948Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT00843375Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT05038332Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
NCT06234748Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
NCT03121300Functional Imaging in Lung SBRT
NCT03787680Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
NCT02059213A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
NCT00156260Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage
NCT00593866Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer
NCT00393796Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma
NCT00146042UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer
NCT03235869Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma
NCT00176735Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
NCT00623935Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia
NCT02958787Vessel Sparing Prostate Radiation Therapy
NCT02400463A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome
NCT00151034Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
NCT00136175Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder
NCT02037230Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas
NCT01973881Quantitative MRI for Myelofibrosis
NCT02013453A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer
NCT00141765Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
NCT02649530A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma
NCT04552418Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors
NCT03300505ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
NCT00810602Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
NCT02097732Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
NCT01661114A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers
NCT03632317A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas
NCT06616155Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT00242190Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
NCT06580054Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma
NCT03416153Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
NCT01519219Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation